This CTD dossier owner and manufacturer develops and manufactures a wide range of pharmaceutical products, focusing on therapies like orthopedics, oncology, probiotics, anti-thrombotics, pain management, and dermatology. Their product portfolio encompasses prescription medications (including cephalosporins), over-the-counter drugs, and supplements. They have manufacturing facilities across numerous regions including the EU and North America, serving over 60 countries. Key dosage forms include injectables, tablets, capsules, and topical solutions. The company prioritizes innovation and affordability, aiming to provide accessible healthcare solutions. They hold GMP certifications and several product patents.